Cyclo Therapeutics Earning Date (CYTH)

USA |NASDAQ |USD

CYTH Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
May 14, 2022 (est) Mar 31, 2022 $-0.48 $-0.34 $-0.76
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
May 14, 2022 (est) Mar 31, 2022 $550.00K $585.12K $358.13K

Cyclo Therapeutics's next estimated earnings date (based on same quarter last year's date) is May 14, 2022 for the fiscal quarter ending Mar 31, 2022.

CYTH Earnings Date & History Chart

CYTH Earnings & Revenue Forecast

CYTH Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 1 $-1.88 $-1.88 $-1.88

CYTH Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 0 / 0 $-1.88 $-1.61 $-1.61

CYTH Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 1 $2.38M $2.38M $2.38M

CYTH Earnings Date & Revenue History

CYTH Earnings History

|
Show More
Show More

CYTH Revenue History

|
Show More
Show More

Cyclo Therapeutics Next Earnings Date & Report

CYTH Mar 2022 (FQ) Earnings Date & Report Preview

CYTH's next estimated earnings date (based on same quarter last year's report date) is May 14, 2022 for the fiscal quarter ending Mar 31, 2022.

Cyclo Therapeutics Previous Earnings Dates & Reports

CYTH Previous Earnings Date & Report Recap: Dec 2021 (FQ)

Cyclo Therapeutics's previous earnings date was Mar 14, 2022 for its fiscal quarter ended Dec 31, 2021.

CYTH's earnings per share (EPS) was $-0.34, beating the consensus analysts forecast of $-0.52 by 34.63%.

The EPS was higher than the previous fiscal quarter (Sep 2021) by -43.35%, and higher than the same period a year before (Dec 2020) by -93.89%.

Revenues were $585.12K, worse than the forecast of $586.00K by -0.15%, up by 44.86% from the previous quarter , and up by 301.90% from the same period last year.

The company reported a net income of $-2.79M.

Free cash flow for the quarter was $-2.61M , compared to $-3.03M last quarter and $-3.06M a year before.

CYTH ended the quarter with $170.99K in total debt, a decrease of -2.63% compared to the previous quarter, and a decrease of -12.06% compared to the same quarter a year before.

CYTH Previous Earnings Date & Report Recap: Dec 2021 (FY)

Cyclo Therapeutics's previous annual earnings date was Mar 14, 2022 for its fiscal year ended Dec 31, 2021.

CYTH's earnings per share (EPS) was $-2.26, beating the consensus analysts forecast of $-2.46 by -8.13% , and higher than the previous year's EPS (Dec 2020) by -75.19%.

Revenues were $1.59M, worse than the forecast of $1.59M by -0.02%, and up by 75.54% from previous year's revenue.

The company reported a net income of $-14.29M.

Cyclo Therapeutics reported a free cash flow of $-15.03M for its fiscal year, compared to $-8.59M a year ago.

The company ended the fiscal year with $170.99K in total debt, a decrease of -12.06% compared to the previous year.